Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

Laura  Pierson

Investor Relations Officer

Mr. David  Patience

Chief Financial Officer

Mr. John  Meduri

Chief Strategy Officer

Mr. Jack  Phillips

Chief Executive Officer, President & Director

Ms. Maya  Gowri

Senior Vice President & Head of Operations

Mr. Lawrence Michael Mertz

Chief Technology Officer

Mr. Chris  Thode

Senior Vice President of US Commercial

Ms. Rita  Boukamel

Senior Vice President & Head of EMEA

Accelerate Diagnostics, Inc.

Accelerate Diagnostics, Inc. Management-Struktur

Informationen zum Management